The need for tools to optimize treatment based on a patient's personal response to treatment is critical for the future of cancer therapy. Rna Diagnostics has developed a novel diagnostic technology to address this very large unmet medical need. The RNA Disruption Assay, a molecular test performed at an early treatment time point, predicts with a very high degree of certainty whether a patient will or will not achieve a survival benefit from a chosen drug regimen

Rna Diagnostics logo



Event details

Date: January 8 - 10, 2024

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


18 in total